Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

25 Jul, 2018, 22:26 BST BioArctic Announces Detailed Results of the BAN2401 Phase 2b Study in Early Alzheimer's Disease Presented at AAIC 2018

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced on July 6 the positive topline results from the clinical Phase 2b study with BAN2401 in...


25 Jul, 2018, 15:00 BST AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (Combined Endpoint)

CONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN'S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY The first...


25 Jul, 2018, 14:00 BST Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Plus: – Genomic Analysis of Alzheimer's Study May Enable a Precision Medicine Approach Significant reductions in the risk of mild cognitive...


25 Jul, 2018, 12:30 BST Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System

Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System Accuray...


25 Jul, 2018, 08:00 BST New Research Demonstrates Beckman Coulter's Access hsTnI's Diagnostic Accuracy in Safely Ruling Out Acute Coronary Syndrome in 2 Hours

First study to validate Access hsTnI's clinical performance within five established accelerated diagnostic pathways for the assessment of patients...


24 Jul, 2018, 17:00 BST Endoscopy Publishes the Dayb Phase III Trial for Plenvu®(Ner1006), the First One Litre Peg Bowel Preparation[i]

- PLENVU[® ]was as effective as sodium picosulfate and magnesium salt solution (CITRAFLEET[® ]) at achieving overall bowel cleansing...


23 Jul, 2018, 16:00 BST IMBA - Institut für Molekulare Biotechnologie GmbH: Growing Brain Cancer in a Dish

For the first-time, researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - develop organoids, that...


23 Jul, 2018, 08:00 BST Perflow Medical Announces the First Clinical Use of the Cascade™ Dynamic Non-Occlusive Remodeling Net

And expands production capabilities through acquisition of TailorMed Ltd. Perflow Medical, an Israeli-based medical device company that...


19 Jul, 2018, 21:51 BST Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome...


19 Jul, 2018, 15:54 BST Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


19 Jul, 2018, 15:20 BST Researchers Are One Step Closer to Developing Eye Drops to Treat Age-related Macular Degeneration (AMD)

Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related...


19 Jul, 2018, 13:30 BST ENDOSCOPY Publishes the MORA Phase III Trial for PLENVU® (NER1006), the Only 1 Litre Peg Based Bowel Preparation[i]

Norgine B.V. today announced that results from the PLENVU® Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed medical...


19 Jul, 2018, 11:53 BST Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials

Green Valley plans to submit the application for treatment to the China National Drug Administration this Year Shanghai Green Valley...


18 Jul, 2018, 22:07 BST BioArctic: Late Breaking Phase 2b Study Results of BAN2401 in Alzheimer's Disease Will be Webcast Live From AAIC 2018 by Eisai

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B). As previously announced, the BAN2401 Phase 2b clinical study results will be presented in an...


18 Jul, 2018, 13:15 BST Clinical Trial Developments Increasing Level of Successful Cancer Treatments

MarketNewsUpdates.com News Commentary Big Pharma and pioneering Biotech firms are forging ahead with Clinical Trials for identifying advanced...


17 Jul, 2018, 08:30 BST SQN Clinical Launches the Most Advanced Real-time Analytics Tool for Clinical Research

SQN Clinical launches SQN Health Analytics, providing clinical professionals with a clear picture of the entire trial process and all collected...


12 Jul, 2018, 14:36 BST Targovax and SOTIO Announce First Patient Dosed in Phase I/II Combination Trial of ONCOS-102 With DCVAC

Targovax ASA (OSE: TRVX), a clinical stage company focused on developing and commercializing immune activators to target hard to treat solid...


11 Jul, 2018, 17:45 BST Aurigene Announces First in Human Dosing with RoRγt Inverse Agonist AUR-101

- Phase 1 data from the study expected to be available by December 2018 Aurigene, a biotechnology company focused on discovering and developing...


11 Jul, 2018, 13:15 BST Drug Developers Expecting Significant Clinical and Economic Benefits by Targeting Newest Drug Therapies

MarketNewsUpdates.com News Commentary Clinical trial development is advancing ways to support sponsors and partnerships as biotech and...


11 Jul, 2018, 12:15 BST CannTrust and Australia's Gold Coast University Hospital Partner in ALS Clinical Trial

The study is designed to evaluate the efficacy of CannTrust's Cannabidiol Oil Capsules in slowing Amyotrophic Lateral Sclerosis (ALS) progression...


11 Jul, 2018, 08:17 BST Cantargia Receives Intention to Grant Notification From EPO for Expanded Patent Protection in Treatment of Solid Tumours

Cantargia AB announce that the European Patent Office (EPO) has issued an Intention to grant notification for the company's divisional (second,...


11 Jul, 2018, 08:07 BST Gyncentrum Clinic: World's First Pregnancies With AneVivo Egg Donation in Poland

Gyncentrum Clinic has just announced the world's first pregnancies using a more natural fertilisation method with donor eggs. "We are very happy...


10 Jul, 2018, 18:01 BST OxThera Updates on Phase 3 Study With Oxabact® in Primary Hyperoxaluria

OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that the Phase 3 study with Oxabact® in Primary...


10 Jul, 2018, 11:49 BST BioArctic Receives Regulatory Approval in Finland for a Clinical Study in Patients With Complete Spinal Cord Injury

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has received approval by Fimea, the Finnish Medicines Agency, and...


10 Jul, 2018, 08:01 BST Otsuka Medical Devices, Otsuka Holdings and ReCor Medical Announce Signing of Merger Agreement

Otsuka Holdings Co., Ltd. ("Otsuka Holdings"), Otsuka Medical Devices Co., Ltd. ("Otsuka Medical Devices") and ReCor Medical, Inc. ("ReCor")...


Most Viewed Clinical Trials & Medical Discoveries